India, Aug. 7 -- Doximity, Inc. (DOCS), a digital platform for medical professionals, reported first-quarter fiscal 2027 results, reflecting revenue above guidance while earnings declined from the prior year. In addition, the company provided guidance for the second quarter, lifted revenue guidance and updated its adjusted EBITDA forecast for the full fiscal year 2027.
Following the news, DOCS is up over 43% at $29.50.
Also, the company's clinical AI assistant, Doximity Ask, was recognised as the top-performing U.S.-based model in the NOHARM benchmark, said Jeff Tangney, co-founder and CEO of Doximity.
For the first quarter of fiscal year 2027, Net income slipped to $24.32 million or $0.13 per share, from $53.32 million or $0.27 per shar...